Available datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab, When Added to Avonex® (Interferon Beta-1a), in Subjects With Relapsing-Remitting Multiple Sclerosis'

The purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting Multiple Sclerosis (MS).

本研究旨在评估联合应用那他珠单抗（natalizumab）与AVONEX治疗确诊为复发缓解型多发性硬化症（relapsing remitting Multiple Sclerosis, MS）患者的安全性，以及该疗法延缓疾病进展的有效性。